XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' deficiency (Details) - USD ($)
 1 Months Ended 3 Months Ended
Aug. 15, 2022
Aug. 15, 2022
Aug. 10, 2022
Jul. 01, 2020
Jul. 31, 2021
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Oct. 31, 2021
Stockholders' Equity (Deficiency) [Line Items]                    
Shares authorized (in Shares)           170,000,000   170,000,000   150,000,000
Par value, price per share           $ 0.00001   $ 0.00001    
Loan amount (in Dollars)           $ 1,325,638 $ 14,097,414      
Common stock, shares issued (in Shares)             4,175,889      
Convertible note payable, (in Dollars)           1,262,030        
Net proceeds (in Dollars) $ 8,200,000         $ 8,235,110      
Offering expenses (in Dollars) 1,000,000                  
Fair value of warrants issued (in Dollars) $ 200,000         175,349      
Percentage of diluted shares outstanding 2.00%       2.00%          
Stock price per share $ 4 $ 4             $ 5.48  
Common stock, shares issued (in Shares) 109,833                  
Fair value amount (in Dollars) $ 439,332 $ 439,332       208   $ 180    
Stock-based compensation expense (in Dollars)           $ 0 439,332      
Fair value of the warrants (in Dollars)       $ 856,170            
Offering price percentage     125.00%              
Long Term Debt Portion of Unamortized Debt Discounts [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Loan amount (in Dollars)             $ 16,534,988      
Common Stock [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Shares authorized (in Shares)                   10,000,000
Per share value                   $ 0.00001
Shares authorized (in Shares)                   170,000,000
Par value, price per share                   $ 0.00001
Preferred stock, par value           $ 0.00001 $ 0.00001      
Preferred stock, shares authorized (in Shares)           20,000,000 20,000,000      
Shares issued (in Shares)           2,822,472        
Common stock, shares issued (in Shares)             2,300,000      
Representative Warrants [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Stock price per share     $ 5              
Aggregate of shares (in Shares)     100,000              
Shares sold percentage     5.00%              
Warrant [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Stock price per share $ 4 $ 4   $ 5.48            
warrants issued (in Shares)   300,000                
Exercisable duration 5 years 5 years                
Price per share $ 4 $ 4                
Common stock, shares received (in Shares) 157,143 157,143                
Expected volatility percentage 54.80%     49.00%            
Risk-free interest rate percentage 2.91%     0.89%            
Expected life 5 years     5 years            
Exercise price $ 5 $ 5   $ 4            
Fair value of the warrants (in Dollars) $ 175,349                  
Common Stock [Member] | Capital Market Advisory Agreement [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Price per share         $ 0.001          
Common Stock [Member] | Initial Underwritten Public Offering [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Par value, price per share $ 0.00001 0.00001                
Issuance of common stock, shares (in Shares) 2,300,000                  
Price per share $ 4 $ 4                
Common stock, shares issued (in Shares) 2,300,000                  
Underwriter Agreement [Member] | Representative Warrants [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Price per share     $ 0.00001              
Common stock, shares issued (in Shares)     2,300,000              
Offering price per share     $ 4              
Convertible Notes Payable [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Loan amount (in Dollars)           $ 2,686,914        
Convertible notes (in Dollars)           $ 537,383        
Related Parties [Member] | Convertible Notes Payable [Member]                    
Stockholders' Equity (Deficiency) [Line Items]                    
Common stock, shares issued (in Shares)             353,272      
Convertible debt (in Dollars)             $ 2,437,574